The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 7, 2017

Study Completion Date

February 7, 2017

Conditions
Gastroesophageal Reflux
Interventions
DRUG

PPI therapy

"PPI therapy (medication has FDA approval) for 8 weeks in children with proven GERD.~The medication used (esomeprazole) in this trial is approved by the FDA"

PROCEDURE

Stool sample

Stool sample will be obtained before initiation of PPI (before PPI therapy)

PROCEDURE

Stool sample

Stool sample will be obtained 4 weeks after initiation of PPI (under PPI therapy)

PROCEDURE

Stool sample

Stool sample will be obtained 8 weeks after termination of PPI therapy (after PPI therapy).

Trial Locations (1)

8036

Department of Pediatric and Adolescent Surgery, Medical University of Graz, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT02359604 - The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study | Biotech Hunter | Biotech Hunter